NIA
Constantiam Bio Gets $485K Grant From National Institute on Aging for Alzheimer's Tool Development
The funding will be used to advance a tool for interpreting risk variants associated with Alzheimer’s disease and related dementias.
Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA
The blood-based test is designed to detect changes in levels of microRNAs that are enriched in specific brain regions affected by Alzheimer's disease.
Both recent FDA draft guidance and a new research framework encourage the use of biomarker diagnostics to assess Alzheimer's before symptoms emerge.
Alzheimer's Disease Neuroimaging Initiative Enters Third Phase
The initiative was launched to conduct a large-scale study of cognitive impairment and Alzheimer's disease to advance the discovery of biomarkers of the conditions.